CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infection
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接:
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE186360
下载链接
链接失效反馈官方服务:
资源简介:
SARS-CoV-2 has caused a historic pandemic of respiratory disease (COVID-19) and current evidence suggests severe disease is associated with dysregulated immunity within the respiratory tract1,2. However, the innate immune mechanisms that mediate protection during COVID-19 are not well defined. Here we characterize a mouse model of SARS-CoV-2 infection and find that early CCR2-dependent infiltration of monocytes restricts viral burden in the lung. We find that a recently developed mouse-adapted MA-SARS-CoV-2 strain, as well as the emerging B.1.351 variant, trigger an inflammatory response in the lung characterized by expression of pro-inflammatory cytokines and interferon-stimulated genes. Using intravital antibody labeling, we demonstrate that MA-SARS-CoV-2 infection leads to increases in circulating monocytes and an influx of CD45+ cells into the lung parenchyma that is dominated by monocyte-derived cells. scRNA-seq analysis of lung homogenates identified a hyper-inflammatory monocyte profile. We utilize this model to demonstrate that mechanistically, CCR2 signaling promotes infiltration of classical monocytes into the lung and expansion of monocyte-derived cells. Parenchymal monocyte-derived cells appear to play a protective role against MA-SARS-CoV-2, as mice lacking CCR2 showed higher viral loads in the lungs, increased lung viral dissemination, and elevated inflammatory cytokine responses. These studies have identified a CCR2-monocyte axis that is critical for promoting viral control and restricting inflammation within the respiratory tract during SARS-CoV-2 infection. 8 samples in total corresponding to different mice. 4 samples are from mock, control mice. 4 samples are from SARS-CoV-2 infected mice.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发了具有历史意义的呼吸道疾病(COVID-19)大流行,现有研究证据表明,重症疾病与呼吸道内的免疫失调密切相关<sup>1,2</sup>。然而,介导COVID-19防护效应的先天免疫机制尚未得到明确阐明。本研究对一种SARS-CoV-2感染小鼠模型进行了表征,发现早期CCR2依赖的单核细胞浸润可限制肺部的病毒负荷。研究发现,新近开发的小鼠适应型MA-SARS-CoV-2毒株以及新兴的B.1.351变异株,均可触发肺部炎症反应,其特征为促炎细胞因子与干扰素刺激基因的表达上调。通过活体抗体标记实验,本研究证实MA-SARS-CoV-2感染会导致循环单核细胞增多,并使CD45阳性细胞涌入肺实质,其中以单核细胞衍生细胞为主。对肺组织匀浆进行的单细胞RNA测序(single-cell RNA sequencing, scRNA-seq)分析鉴定出了一种高炎症性单核细胞表型。利用该模型,本研究从机制层面证实CCR2信号通路可促进经典单核细胞向肺部浸润,并扩增单核细胞衍生细胞群体。肺实质内的单核细胞衍生细胞似乎对MA-SARS-CoV-2具有防护作用:缺失CCR2的小鼠肺部病毒负荷更高、肺部病毒播散更为严重,且促炎细胞因子反应增强。本研究明确了一条CCR2-单核细胞轴,该轴在SARS-CoV-2感染期间对于促进病毒控制、限制呼吸道内炎症反应至关重要。本数据集共包含8个样本,均来自不同小鼠:其中4个样本取自空白对照(mock)小鼠,剩余4个样本取自SARS-CoV-2感染小鼠。
创建时间:
2021-11-18



